Inflammatory markers in lean Polycystic Ovary Syndrome subjects are not associated with the spectrum of dyslipidemia
HIGHLIGHTS 1. Polycystic ovarian syndrome (PCOS) might be a condition of chronic low degree inflammation and dyslipidemia. 2. Association between inflammation markers and dyslipidemia in PCOS patients was investigated. 3. Dyslipidemia and chronic low degree inflammation were present in lean PCOS pat...
Saved in:
Main Authors: | Elisia Atnil (Author), Andon Hestiantoro (Author), Oki Riayati (Author), Ririn Rahmala Febri (Author), Naylah Muna (Author) |
---|---|
Format: | Book |
Published: |
Universitas Airlangga,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Altered expression of kisspeptin, dynorphin, and related neuropeptides in polycystic ovary syndrome: A cross-sectional study
by: Andon Hestiantoro, et al.
Published: (2024) -
Hypoadiponectinemia: A useful marker of dyslipidemia in women with polycystic ovary syndrome
by: Chih-Yuan Chang, et al.
Published: (2012) -
Dyslipidemia involvement in the development of polycystic ovary syndrome
by: Qi Liu, et al.
Published: (2019) -
Visceral Adipose Tissue was Associated with Increased Risk of Insulin Resistance in Lean Polycystic Ovarian Syndrome, Independent with Retinol Binding Protein-4
by: Vita Silvana, et al.
Published: (2020) -
Lean Polycystic Ovary Syndrome: A Narrative Review
by: Aboubakr Elnashar
Published: (2024)